Literature DB >> 11170990

Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection.

N P Hoe1, J Vuopio-Varkila, M Vaara, D Grigsby, D De Lorenzo, Y X Fu, S J Dou, X Pan, K Nakashima, J M Musser.   

Abstract

Streptococcal inhibitor of complement (Sic) is a highly polymorphic extracellular protein made predominantly by serotype M1 group A Streptococcus (GAS). New variants of the Sic protein frequently appear in M1 epidemics as a result of positive natural selection. To gain further understanding of the molecular basis of M1 epidemics, the sic gene was sequenced from 471 pharyngitis and 127 pyogenic and blood isolates recovered from 598 patients living in metropolitan Helsinki, Finland, during a 37-month population-based surveillance study. Most M1 GAS subclones recovered from pyogenic infections and blood were abundantly represented in the pool of subclones causing pharyngitis. Alleles shared among the pharyngitis, pyogenic, and blood samples were identified in throat isolates a mean of 9.8 months before their recovery from pyogenic infections and blood, which indicates that selection of most sic variants occurs on mucosal surfaces. In contrast, no variation was identified in the emm and covR/covS genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170990     DOI: 10.1086/318543

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

Review 1.  Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions.

Authors:  S D Reid; N P Hoe; L M Smoot; J M Musser
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2.

Authors:  Izabela Sitkiewicz; Michal J Nagiec; Paul Sumby; Stephanie D Butler; Colette Cywes-Bentley; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

Review 3.  A decade of molecular pathogenomic analysis of group A Streptococcus.

Authors:  James M Musser; Samuel A Shelburne
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

4.  Distribution of secretory inhibitor of platelet microbicidal protein among anaerobic bacteria isolated from stool of children with diarrhea.

Authors:  Iuri B Ivanov; Viktor A Gritsenko
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

5.  Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus.

Authors:  Morgan A Pence; Suzan H M Rooijakkers; Anna L Cogen; Jason N Cole; Andrew Hollands; Richard L Gallo; Victor Nizet
Journal:  J Innate Immun       Date:  2010-09-01       Impact factor: 7.349

Review 6.  Molecular insight into invasive group A streptococcal disease.

Authors:  Jason N Cole; Timothy C Barnett; Victor Nizet; Mark J Walker
Journal:  Nat Rev Microbiol       Date:  2011-09-16       Impact factor: 60.633

7.  High Incidence of Invasive Group A Streptococcus Disease Caused by Strains of Uncommon emm Types in Thunder Bay, Ontario, Canada.

Authors:  Taryn B T Athey; Sarah Teatero; Lee E Sieswerda; Jonathan B Gubbay; Alex Marchand-Austin; Aimin Li; Jessica Wasserscheid; Ken Dewar; Allison McGeer; David Williams; Nahuel Fittipaldi
Journal:  J Clin Microbiol       Date:  2015-10-21       Impact factor: 5.948

8.  The Mga Regulon but Not Deoxyribonuclease Sda1 of Invasive M1T1 Group A Streptococcus Contributes to In Vivo Selection of CovRS Mutations and Resistance to Innate Immune Killing Mechanisms.

Authors:  Guanghui Liu; Wenchao Feng; Dengfeng Li; Mengyao Liu; Daniel C Nelson; Benfang Lei
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

9.  emm1/sequence type 28 strains of group A streptococci that express covR at early stationary phase are associated with increased growth and earlier SpeB secretion.

Authors:  Chuan Chiang-Ni; Po-Xing Zheng; Yueh-Ren Ho; Hsiu-Mei Wu; Woei-Jer Chuang; Yee-Shin Lin; Ming-T Lin; Ching-Chuan Liu; Jiunn-Jong Wu
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

10.  The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins.

Authors:  Barbara A Fernie-King; David J Seilly; Peter J Lachmann
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.